ArticleHemaSphere2024

Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant.

Prashant R Tembhare et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.